USC’s Next Chapter in Innovating Brain Health with Julius Fridriksson

Be the first to hear about the University of South Carolina’s (USC) bold vision for transforming neurological care and research in South Carolina at the next SCbio Breakfast and Bio. Julius Fridriksson, Ph.D., CCC-SLP, vice president for research at the University of South Carolina, will highlight how this initiative builds upon the institution’s existing brain health network.

At the heart of this vision is the new Brain Health Center and the recently announced Neuroscience Hospital and Rehabilitation Center, currently under development as part of USC’s upcoming Health Sciences Campus, in the Bull Street District. Slated to open in 2026, these facilities will support a growing elderly population and rising rates of neurological disease through state-of-the-art clinical care, interdisciplinary research and education.

Attendees will learn how this initiative builds upon USC’s existing Brain Health Network to create a “continuum of care,” bridging research, clinical application and long-term rehabilitation. This regional breakfast, sponsored by Dominion Energy, will be held on Thursday, September 4, at 8 a.m. in Columbia.

Fridriksson is an Icelandic-American clinical neuroscientist and internationally recognized leader in the study of brain-language relationships. With over 250 peer-reviewed publications and more than $50 million in National Institutes of Health (NIH) funding, including four NIH-classified clinical trials, his work has redefined the scientific understanding of aphasia, stroke recovery and the neural architecture of human communication. His research combines high-resolution neuroimaging, clinical trials and computational modeling to develop brain-based therapies that have improved the lives of thousands of patients with language and cognitive disorders.

Fridriksson built his research portfolio from the ground up, studying post-stroke neuroscience and managing a growing, thriving team of researchers. A primary driver of this work is the interdisciplinary Center for the Study of Aphasia Recovery (C-STAR). Collaboration is at the heart of C-STAR’s mission. The center focuses on four projects, including two at USC, one at Johns Hopkins University and one at the University of California, Irvine. Each project examines a different aspect of aphasia, a communication disorder characterized by difficulty understanding and/or generating speech that results from damage to the left hemisphere of the brain, often caused by a stroke.

As a prominent member of the USC research community for over two decades, Fridriksson oversees a growing research enterprise across science, health, engineering and technology. He has served as a faculty member in the Department of Communication Sciences and Disorders at the Arnold School of Public Health since 2001 and as SmartState Endowed Chair of Memory and Brain Function, directing the SMARTBrain™ Center since 2016. He also co-directs the cutting-edge USC McCausland Center for Brain Imaging.

Fridriksson holds a doctorate in philosophy, speech and hearing sciences, with a minor in statistics from the University of Arizona.

Join now to enjoy expanded member benefits!

Enjoy exclusive member content, special events, savings, networking and more

Paige Durham

SCbio is pleased to welcome Paige Durham to the team as communications coordinator to creatively and effectively communicate the value of the life science association’s programs and initiatives.

Durham will be responsible for developing and distributing high-quality content across multiple communications channels to build, advance and grow South Carolina’s life sciences industry, a key business sector for economic prosperity for the Palmetto State.

“SCbio is excited to welcome Paige to our team as our new communications coordinator. Paige brings fresh ideas and a strong background in communications that will be invaluable as we continue to strengthen our engagement with our audience,” said SCbio President and CEO James Chappell. “We are confident that her skills and experience will be crucial in advancing our communication strategies and supporting our mission.”

Before joining SCbio, Durham was the Membership and Communications Manager at the South Carolina Pharmacy Association (SCPhA), where she used her photography, design and writing skills to create content tailored to pharmacy professionals. Durham’s effective communication skills guaranteed the delivery of brand-specific material that captured the eye of her audience.

During her time at SCPhA, Durham created and edited the Palmetto Pharmacist Journal, using her creative vision to showcase members, educational institutions and industry news. Her communications efforts successfully gained new followers for the organization over the course of a year, increasing brand visibility and promoting the pharmacy profession.

Durham holds a Bachelor of Science in hospitality and tourism management and a Bachelor of Science in business administration from the College of Charleston.

Tamia Sumpter

Tamia is a driven senior undergraduate Bioengineering student currently enrolled at Clemson University. With a strong foundation in her field, she has honed her skills through hands-on experience in research and development at Eli Lilly & Company. During her time in the ADME department, Tamia contributed significantly by working on siRNAs and their applications in finding In Vitro-In Vivo Correlation (IVIVC). Looking ahead, Tamia has set her sights on a promising career in law. She aspires to specialize in Intellectual Property Law, with a particular focus on serving as in-house counsel for leading medical device or pharmaceutical companies. Her enthusiasm for this role is palpable as she prepares to embark on her legal journey! She is also a proud member of the Omicron Phi chapter of Delta Sigma Theta Sorority, Inc., PEER Mentor for Clemson PEER/WiSE, and currently serves as the President of Clemson Bioengineering Organization (CBO). With her unique blend of scientific knowledge and legal interests, Tamia is poised to make a meaningful impact in the healthcare and life sciences industries.